Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Lancet (London, England)
|
June 13, 1981
Intestinal permeability in patients with eczema and food allergy
P G Jackson, M H Lessof, R W Baker, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
September 1, 1995
Assessment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients
J P John, K N Chengappa, R W Baker, et al.
Psychopharmacology Bulletin
|
January 1, 1996
Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo
R W Baker, D Ames, D S Umbricht, et al.
Behavioural Pharmacology
|
May 1, 2002
Acute behavioral and physiological effects of modafinil in drug abusers
C R Rush, T H Kelly, L R Hays, et al.
Psychopharmacology Bulletin
|
January 1, 1988
Clozapine efficacy in schizophrenic nonresponders
R R Conley, S C Schulz, R W Baker, et al.
Lancet (London, England)
|
February 27, 1971
Improvement in nerve conduction following treatment in newly diagnosed diabetics
J D Ward, C G Barnes, D J Fisher, et al.
Atherosclerosis
|
May 1, 1974
Lipid deposits in ageing human arteries, tendons and fascia
C W Adams, O B Bayliss, R W Baker, et al.
Psychopharmacology Bulletin
|
January 1, 1996
The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF)
K N Chengappa, A Gopalani, M K Haught, et al.
The Journal of Clinical Psychiatry
|
October 15, 1998
Clozapine withdrawal-emergent dystonias and dyskinesias: a case series
S Ahmed, K N Chengappa, V R Naidu, et al.
The Journal of Clinical Psychiatry
|
April 1, 1994
The prevalence of akathisia in patients receiving stable doses of clozapine
K N Chengappa, M D Shelton, R W Baker, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Lancet (London, England)
|
June 13, 1981
Intestinal permeability in patients with eczema and food allergy
P G Jackson, M H Lessof, R W Baker, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
September 1, 1995
Assessment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients
J P John, K N Chengappa, R W Baker, et al.
Psychopharmacology Bulletin
|
January 1, 1996
Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo
R W Baker, D Ames, D S Umbricht, et al.
Behavioural Pharmacology
|
May 1, 2002
Acute behavioral and physiological effects of modafinil in drug abusers
C R Rush, T H Kelly, L R Hays, et al.
Psychopharmacology Bulletin
|
January 1, 1988
Clozapine efficacy in schizophrenic nonresponders
R R Conley, S C Schulz, R W Baker, et al.
Lancet (London, England)
|
February 27, 1971
Improvement in nerve conduction following treatment in newly diagnosed diabetics
J D Ward, C G Barnes, D J Fisher, et al.
Atherosclerosis
|
May 1, 1974
Lipid deposits in ageing human arteries, tendons and fascia
C W Adams, O B Bayliss, R W Baker, et al.
Psychopharmacology Bulletin
|
January 1, 1996
The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF)
K N Chengappa, A Gopalani, M K Haught, et al.
The Journal of Clinical Psychiatry
|
October 15, 1998
Clozapine withdrawal-emergent dystonias and dyskinesias: a case series
S Ahmed, K N Chengappa, V R Naidu, et al.
The Journal of Clinical Psychiatry
|
April 1, 1994
The prevalence of akathisia in patients receiving stable doses of clozapine
K N Chengappa, M D Shelton, R W Baker, et al.
Page
of 8